Kim, Jee Hyun
Park, Chun Hui J.
Reddy, Preethi V.
Khanra, Sourav
Arumugham, Shyam Sundar
Venkatasubramanian, Ganesan
Debnath, Monojit
Arasappa, Rashmi
Ashton, Melanie M.
Panizzutti, Bruna
Turner, Alyna
Tholasappa, Varshitha
Shukla, Devangi
Sadashiva, Sachin Tudur
Raj, Justin
Dombale, Sudhakar
Dean, Olivia
Mohebbi, Mohammadreza
Vieta, Eduard
Pacchiarotti, Isabella
Umesh, Shreekantiah
Walder, Ken
Yatham, Lakshmi
Baek, Ji Hyun
Goyal, Nishant
Reddy, Y. C. Janardhan
Kesavan, Muralidharan
Berk, Michael
Funding for this research was provided by:
Australian Research Council
Stanley Medical Research Institute
Article History
Received: 11 March 2026
Accepted: 24 March 2026
First Online: 3 April 2026
Declarations
:
: The authors declare that all procedures contributing to this work comply with the ethical standards of the relevant national and institutional committees on human experimentation and with the Helsinki Declaration of 1975, as revised in 2008. The TIDE trial protocol is approved by the Deakin University Human Research Ethics Committee (DUHREC project ID: JK02900). The trial has commenced recruitment at NIMHANS (NIMHANS Institute Ethics Committee approved project ID: NIMHANS/EC (BEH.SC.DIV.)/2025) and CIP (CIP Institute Ethics Committee approved project ID: IEC/CIP/2022-23/171) but not in any other sites. Prior to commencing any trial-related activity, written informed consent is obtained from all participants.
: All authors meet standard authorship criteria and approved this submission for publication.
: The authors declare no competing interests.